Thermo Fisher Scientific acquires Solventum’s Purification & Filtration business for $4.1 billion, aiming to boost biologics development and manufacturing expertise by 2025. The acquisition brings
Tag: corporate strategy
Top Executive Sells Company Shares: Inside the Strategy
Brent Sabatini, Vir Biotechnology’s Senior VP and Chief Accounting Officer, sold 1,562 shares for $14,291 to address tax obligations from vesting restricted stock units. This
Massive Deal Alert! Johnson & Johnson Makes a Power Move in Psychiatry
Johnson & Johnson’s Bold Acquisition in Neuroscience In a groundbreaking transaction, Johnson & Johnson (J&J) is set to acquire Intra-Cellular Therapies, granting it rights to